Fragment screening by NMR: collaboration with F. Allain group published
Screening by NMR in combination with a novel hybrid structure determination approach has been used assess the drugability to of the nucleocapsid N-protein of SARS-CoV-2.
Screening by NMR in combination with a novel hybrid structure determination approach has been used assess the drugability to of the nucleocapsid N-protein of SARS-CoV-2.
